Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Primary Objective To determine if colestipol hydrochloride tablets can accelerate the
elimination of teriflunomide. Teriflunomide will be administered for 14 days followed by
colestipol dosing of 11 days. Total duration of the study is 40 days.
Secondary Objectives To collect information on the pattern of side effects with use of
colestipol hydrochloride after teriflunomide administration and to determine the best
duration of therapy needed for adequate elimination
Phase:
Phase 1
Details
Lead Sponsor:
Derrick Scott Robertson
Collaborators:
Genzyme, a Sanofi Company University of South Florida